Skip to main content

Table 1 Characteristics of patients with Bacillus cereus bloodstream infection

From: Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections

Variable

All patients (n = 29)

Empirical therapy that was deemed

P value

Appropriate (n = 9)

Inappropriate (n = 20)

Age, years (median, range)

65.3 (18–89)

68 (18–89)

65 (47–83)

0.743

Sex (male/female)

16/13

4/5

12/8

0.688

No. of patients with comorbidity

 Diabetes mellitus

8

3

5

0.675

 Malignancy

15

4

11

0.700

 Liver cirrhosis

4

1

3

1.00

 Immunosuppressant

5

2

3

0.633

 Neutropenia

4

0

4

0.280

No. of patients with implanted device

 Central venous catheter

6

1

5

0.633

 Peripheral venous catheter

22

8

14

0.382

 Others

7

3

4

0.642

Source of BSI

 Total catheter-related infection

20

7

13

0.675

  Peripheral blood catheter

15

6

9

0.427

  Central venous catheter

5

1

4

1.00

 Othersa

5

0

5

0.153

 Unknown

4

2

2

0.568

Laboratory data (average, range)

 White blood cell count (/μL)

7497 (100–22,200)

9630 (1800–22,200)

6537 (100–16,100)

0.052

 C-reactive protein (g/dL)

4.19 (0.04–16.6)

3.79 (0.04–16.6)

3.34 (0.17–13.7)

0.514

 Albumin (g/dL)

3.29 (2.10–4.20)

2.71 (2.10–3.90)

3.45 (2.40–4.20)

0.206

  1. aOther sources of BSI in the inappropriate empirical therapy group include febrile neutropenia (2 cases), possible infective endocarditis according to modified Duke’s criteria (2 cases), and peritonitis (1 case)